Changchun High-Tech: The cooperative product Pediatric Golden Cough Granules was approved for marketing in China

2025-01-03 19:51:18

Changchun High-Tech announced that the Children's Golden Cough Granules applied for by Changchun Jinyian Pharmaceutical Co., Ltd., a subsidiary of its controlling subsidiary Changchun Jinsai Pharmaceutical Co., Ltd., and Beijing Oriental Yunjia Pharmaceutical Co., Ltd., a partner of the company's controlling subsidiary Jilin Huakang Pharmaceutical Co., Ltd., have been approved for marketing through the priority review and approval procedure of the National Medical Products Administration.

BOE JD

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Singapore investigates Nvidia server export fraud
                            2025-03-03

                                    Shenzhen: By 2027, there will be more than 1,200 companies related to the embodied intelligent robot industry cluster
                            2025-03-03

                                    Hongqi Chain Store: Deputy General Managers Zhang Ying, Wan Chun, Hong Fan and Yang Yuanbin resigned
                            2025-03-03

                                    Shenzhen: Focus on supporting key core technologies such as core components of embodied intelligent robots, AI chips, and bionic dexterous hands
                            2025-03-03

                                    Intel showcases Xeon 6 processor-based network infrastructure at MWC2025
                            2025-03-03